Effective 1 de janeiro, 2022, this policy is being updated to include CPT code 0564T [Oncology,

chemotherapeutic drug cytotoxicity assay of cancer stem cells (CSCs), from cultured CSCs and primary tumor cells, categorical drug response reported base on percent of cytotoxicity observed a minimum of 14 drugs or drug combinations]. Coverage for Medicare Advantage plans

will change from prior authorization review required to not covered. CPT code 0564T will remain not medically necessary for commercial products. Please click here for additional details.